These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17575123)

  • 1. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.
    Leman ES; Schoen RE; Weissfeld JL; Cannon GW; Sokoll LJ; Chan DW; Getzenberg RH
    Cancer Res; 2007 Jun; 67(12):5600-5. PubMed ID: 17575123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
    Leman ES; Schoen RE; Magheli A; Sokoll LJ; Chan DW; Getzenberg RH
    Clin Cancer Res; 2008 Mar; 14(5):1349-54. PubMed ID: 18316554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer.
    Walgenbach-Brunagel G; Burger B; Leman ES; Walgenbach KJ; Tolba R; Heukamp L; Hirner A; Getzenberg RH
    J Cell Biochem; 2008 May; 104(1):286-94. PubMed ID: 18044711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon.
    Yoshida I; Suzuki A; Vallée M; Matano Y; Masunaga T; Zenda T; Shinozaki K; Okada T
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1225-31. PubMed ID: 16979948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy.
    Pinsky PF; Schoen RE; Weissfeld JL; Bresalier RS; Hayes RB; Gohagan JK
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):103-10. PubMed ID: 15017502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
    Haug U; Hundt S; Brenner H
    Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of monitoring colorectal adenomas by tumor markers (ROC analysis).
    Stajic S; Novaković R; Kostić N; Josifovski J; Simić P; Katić V; Kovijanić M
    Med Pregl; 1993; 46 Suppl 1():69-71. PubMed ID: 8569613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients.
    Mroczko B; Groblewska M; Wereszczynska-Siemiatkowska U; Kedra B; Konopko M; Szmitkowski M
    Clin Chim Acta; 2006 Sep; 371(1-2):143-7. PubMed ID: 16603145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of autofluorescence colonoscopy for the detection and diagnosis of colonic polyps.
    McCallum AL; Jenkins JT; Gillen D; Molloy RG
    Gastrointest Endosc; 2008 Aug; 68(2):283-90. PubMed ID: 18329642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification criteria for advanced adenomas of the colon by using probe-based confocal laser endomicroscopy: a preliminary study.
    Gómez V; Shahid MW; Krishna M; Heckman MG; Crook JE; Wallace MB
    Dis Colon Rectum; 2013 Aug; 56(8):967-73. PubMed ID: 23838865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EPCA-2: a highly specific serum marker for prostate cancer.
    Leman ES; Cannon GW; Trock BJ; Sokoll LJ; Chan DW; Mangold L; Partin AW; Getzenberg RH
    Urology; 2007 Apr; 69(4):714-20. PubMed ID: 17445657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin is up-regulated in colon adenocarcinoma.
    Kim KY; Kee MK; Chong SA; Nam MJ
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2373-8. PubMed ID: 18006926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for advanced colorectal adenomas: a pooled analysis.
    Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
    Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
    Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.
    Fedarko NS; Jain A; Karadag A; Van Eman MR; Fisher LW
    Clin Cancer Res; 2001 Dec; 7(12):4060-6. PubMed ID: 11751502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.